If You Invested in Aerpio Pharmaceuticals Inc (ARPO)
See the ARPO overviewWhat $1,000 or $10,000 in ARPO Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Jun 26, 2018 |
|---|---|---|---|---|
| $1,000 | $1,486 +49% | — | — | $564 -44% |
| $10,000 | $14,865 +49% | — | — | $5,641 -44% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2021-08-26. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for ARPO$1,000 Investment Over Time
ARPO vs S&P 500Year-by-Year Returns
ARPO annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2018Jun 26, 2018 to Dec 31, 2018 | $58.50 | $25.50 | -56.4% | -56.4% |
| 2019 | $25.50 | $9.35 | -63.3% | -84.0% |
| 2020 | $9.35 | $14.70 | +57.2% | -74.9% |
| 2021Dec 31, 2020 to Aug 26, 2021 | $14.70 | $33.00 | +124.5% | -43.6% |
About Aerpio Pharmaceuticals Inc
Frequently Asked Questions
Aerpio Pharmaceuticals Inc investment returns
How much was $1,000 invested in Aerpio Pharmaceuticals Inc worth at its last close?
If you invested $1,000 in Aerpio Pharmaceuticals Inc (ARPO) 1 year before its last close, on 2020-08-26, your investment was worth $1,486 on 2021-08-26, a +48.6% price return without dividends, growing at a compounded rate of 48.7% per year (CAGR).
Has Aerpio Pharmaceuticals Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare ARPO performance over available time periods.
What is Aerpio Pharmaceuticals Inc's average annual return?
The compound annual growth rate (CAGR) of ARPO’s share price over the 1 year to Aug 26, 2021 is 48.7%, without dividends. Individual years vary a great deal, and ARPO’s best recent full year was 2020 (+57.2%) while the worst was 2019 (-63.3%).
For informational and educational purposes only, not investment advice.